1. Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases

   • Samir Abu-Rumeileh
   • Ahmed Abdelhak
   • Markus Otto

   Review Open access 25 August 2020 Pages: 1133 - 1170

   

2. COVID-19: dealing with a potential risk factor for chronic neurological disorders

   • Tommaso Schirinzi
   • Doriana Landi
   • Claudio Liguori

   Review Open access 27 August 2020 Pages: 1171 - 1178

   

3. Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region

   • Eleonora Del Prete
   • Alessio Francesconi
   • Tuscany Parkinson COVID-19 Participants

   Original Communication 03 September 2020 Pages: 1179 - 1187

4. COVID-19 infection in NMO/SD patients: a French survey

   • Sinéad Zeidan
   • Elisabeth Maillart
   • Caroline Papeix

   Letter to the Editors 12 September 2020 Pages: 1188 - 1190

5. SARS-CoV-2 associated Guillain–Barré syndrome

   • Teodor Pelea
   • Ursula Reuter
   • Bjoern Wito Walther

   Letter to the Editors Open access 08 August 2020 Pages: 1191 - 1194

6. Guillain-Barré syndrome in the COVID-19 era: just an occasional cluster?

   • Gian Luigi Gigli
   • Francesco Bax
   • Mariarosaria Valente

   Letter to the Editors 19 May 2020 Pages: 1195 - 1197

7. Guillain–Barré syndrome in the COVID-19 era: another occasional cluster?

   • Laurent Tatu
   • Sandra Nono
   • Serdar Koçer

   Letter to the Editors 23 June 2020 Pages: 1198 - 1200

8. Reply to "Guillain‑Barré syndrome in the COVID‑19 era another occasional cluster?": Insights from two distinct clusters of Guillain–Barré syndrome detected in Europe in the COVID-19 era

   • Alessandro Marini
   • Alberto Vogrig
   • Gian Luigi Gigli

   Letter to the Editors 04 August 2020 Pages: 1201 - 1202

9. Selective serotonin reuptake inhibitors for functional recovery after stroke: similarities with the critical period and the role of experience-dependent plasticity

   • Colleen L. Schneider
   • Ania K. Majewska
   • Bogachan Sahin

   Review 25 July 2019 Pages: 1203 - 1209

   

10. A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition

    • Hernan Inojosa
    • Undine Proschmann
    • Tjalf Ziemssen

    Review 30 July 2019 Pages: 1210 - 1221

    

11. Physical exercise improves quality of life, depressive symptoms, and cognition across chronic brain disorders: a transdiagnostic systematic review and meta-analysis of randomized controlled trials

    • Meenakshi Dauwan
    • Marieke J. H. Begemann
    • Iris E. C. Sommer

    Review Open access 14 August 2019 Pages: 1222 - 1246

    

12. Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis

    • Tobias Monschein
    • Sabine Salhofer-Polanyi
    • Fritz Leutmezer

    Original Communication Open access 14 September 2020 Pages: 1247 - 1253

    

13. iNPH with parkinsonism: response to lumbar CSF drainage and ventriculoperitoneal shunting

    • Giovanni Mostile
    • Giacomo Portaro
    • Mario Zappia

    Original Communication 19 October 2020 Pages: 1254 - 1265

14. ¹⁸F-FDOPA-PET in pseudotumoral brain lesions

    • Dimitri Renard
    • Laurent Collombier
    • Jean Sebastien Guillamo

    Original Communication 21 October 2020 Pages: 1266 - 1275

    

15. Nationwide population-based incidence and etiologies of pediatric and adult Horner syndrome

    • Jinu Han
    • Seong Yong Park
    • Ju-Yeun Lee

    Original Communication 22 October 2020 Pages: 1276 - 1283

    

16. Mild cognitive impairment with Lewy bodies: blood perfusion with arterial spin labelling

    • Michael J. Firbank
    • John T. O’Brien
    • Alan J. Thomas

    Original Communication Open access 21 October 2020 Pages: 1284 - 1294

    

17. Management of Parkinson's disease patients after DBS by remote programming: preliminary application of single center during quarantine of 2019-nCoV

    • Jinyu Xu
    • Jiali Wang
    • Xi Wu

    Original Communication 26 October 2020 Pages: 1295 - 1303

    

18. PolyQ-expanded ataxin-3 protein levels in peripheral blood mononuclear cells correlate with clinical parameters in SCA3: a pilot study

    • Kathrin Gonsior
    • Gabriele Anna Kaucher
    • Jeannette Hübener-Schmid

    Original Communication Open access 26 October 2020 Pages: 1304 - 1315

    

19. Digital biomarkers can highlight subtle clinical differences in radiologically isolated syndrome compared to healthy controls

    • Mikael Cohen
    • Lydiane Mondot
    • Christine Lebrun

    Original Communication 19 October 2020 Pages: 1316 - 1322

    

20. Serum neurofilament light chain as outcome marker for intensive care unit patients

    • Anna Lena Fisse
    • Kalliopi Pitarokoili
    • Min-Suk Yoon

    Original Communication Open access 23 October 2020 Pages: 1323 - 1329

    

21. The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progression

    • Cecilia Smith Simonsen
    • Heidi Øyen Flemmen
    • Elisabeth Gulowsen Celius

    Original Communication Open access 22 October 2020 Pages: 1330 - 1341

    

22. Characterizing the face in facioscapulohumeral muscular dystrophy

    • T. G. J. Loonen
    • C. G. C. Horlings
    • K. Mul

    Original Communication Open access 28 October 2020 Pages: 1342 - 1350

    

23. SQSTM1 variant in disorders of the frontotemporal dementia–amyotrophic lateral sclerosis spectrum: identification of a novel heterozygous variant and a review of the literature

    • Weishuai Li
    • Han Gao
    • Dongming Zheng

    Original Communication 30 October 2020 Pages: 1351 - 1357

    

24. Usefulness of a single-parameter tool for the prediction of large vessel occlusion in acute stroke

    • Franck Leibinger
    • Thibaut Allou
    • Denis Sablot

    Original Communication 03 November 2020 Pages: 1358 - 1365

    

25. Underdiagnosis and diagnostic delay in chronic inflammatory demyelinating polyneuropathy

    • Umair J. Chaudhary
    • Yusuf A. Rajabally

    Original Communication Open access 10 November 2020 Pages: 1366 - 1373

    

26. Consciously processing balance leads to distorted perceptions of instability in older adults

    • Toby J. Ellmers
    • Elmar C. Kal
    • William R. Young

    Original Communication Open access 03 November 2020 Pages: 1374 - 1384

    

27. Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren’s syndrome

    • Anne B. Tjensvoll
    • Maria B. Lauvsnes
    • Roald Omdal

    Original Communication Open access 30 October 2020 Pages: 1385 - 1394

    

28. Central sensitization in migraine is related to restless legs syndrome

    • Keisuke Suzuki
    • Shiho Suzuki
    • Koichi Hirata

    Original Communication 04 November 2020 Pages: 1395 - 1401

29. Longitudinal changes in the macula and optic nerve in familial dysautonomia

    • Jonathan Kfir
    • Mengfei Wu
    • Gadi Wollstein

    Original Communication 12 November 2020 Pages: 1402 - 1409

    

30. Correction to: Longitudinal changes in the macula and optic nerve in familial dysautonomia

    • Jonathan Kfir
    • Mengfei Wu
    • Gadi Wollstein

    Correction 02 January 2021 Pages: 1410 - 1410

31. Serum BDNF discriminates Parkinson’s disease patients with depression from without depression and reflect motor severity and gender differences

    • Yixian Huang
    • Caili Huang
    • Jiawei Sun

    Original Communication 11 November 2020 Pages: 1411 - 1418

    

32. Myelin oligodendrocyte glycoprotein-antibody-associated disorder: a new inflammatory CNS demyelinating disorder

    • Manjunath Netravathi
    • Vikram Venkappayya Holla
    • Anita Mahadevan

    Original Communication 13 November 2020 Pages: 1419 - 1433

    

33. Cognitive impairments are independently associated with shorter survival in diffuse glioma patients

    • Emma van Kessel
    • Irene M. C. Huenges Wajer
    • Tom J. Snijders

    Original Communication Open access 19 November 2020 Pages: 1434 - 1442

    

34. Cognitive impairment in temporal lobe epilepsy: contributions of lesion, localization and lateralization

    • Thanh Ha Phuong
    • Marion Houot
    • Sophie Dupont

    Original Communication 20 November 2020 Pages: 1443 - 1452

    

35. SQSTM1 gene as a potential genetic modifier of CADASIL phenotype

    • Maria Rosário Almeida
    • Ana Rita Silva
    • Gustavo Cordeiro Santo

    Original Communication 20 November 2020 Pages: 1453 - 1460

    

36. Serum vitamin D, vitamin D receptor and binding protein genes polymorphisms in restless legs syndrome

    • Félix Javier Jiménez-Jiménez
    • Gemma Amo
    • Elena García-Martín

    Original Communication 21 November 2020 Pages: 1461 - 1472

37. Correction to: Serum vitamin D, vitamin D receptor and binding protein genes polymorphisms in restless legs syndrome

    • Félix Javier Jiménez-Jiménez
    • Gemma Amo
    • Elena García-Martín

    Correction 19 February 2021 Pages: 1473 - 1473

38. Repetitive transcranial magnetic stimulation for post-stroke depression: a randomised trial with neurophysiological insight

    • Brenton Hordacre
    • Kristina Comacchio
    • Susan Hillier

    Original Communication 20 November 2020 Pages: 1474 - 1484

    

39. Subcutaneous immunoglobulin dose titration to clinical response in inflammatory neuropathy

    • Mahima Kapoor
    • Ryan Keh
    • Aisling S. Carr

    Original Communication 20 February 2021 Pages: 1485 - 1490

    

40. Superficial siderosis of the central nervous system associated with ventral dural defects: bleeding from the epidural venous plexus

    • Keisuke Takai
    • Makoto Taniguchi

    Original Communication 03 January 2021 Pages: 1491 - 1494

    

41. One nerve suffices: A clinically guided nerve ultrasound protocol for the differentiation of multifocal motor neuropathy (MMN) and amyotrophic lateral sclerosis (ALS)

    • Kai F. Loewenbrück
    • Robin Werner
    • Andreas Hermann

    Original Communication Open access 23 December 2020 Pages: 1495 - 1507

    

42. The erythrocyte sedimentation rate in male adolescents and subsequent risk of Parkinson’s disease: an observational study

    • Camilla Fardell
    • Linus Schiöler
    • Maria Åberg

    Original Communication Open access 04 December 2020 Pages: 1508 - 1516

    

43. Biochemical markers for severity and risk in GBA and LRRK2 Parkinson’s disease

    • Avner Thaler
    • Nurit Omer
    • Anat Mirelman

    Original Communication 03 January 2021 Pages: 1517 - 1525

44. Investigating the 1-year decline in midbrain-to-pons ratio in the differential diagnosis of PSP and IPD

    • Silja Kannenberg
    • Julian Caspers
    • Christian J. Hartmann

    Original Communication Open access 04 December 2020 Pages: 1526 - 1532

    

45. CASPR2 antibody-related movement disorders: case series

    • Sangeeta Scotton
    • Mei See
    • Saiju Jacob

    Letter to the Editors 05 January 2021 Pages: 1533 - 1535

46. Hematopoietic stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: French experience about four patients, under the behalf of French society for bone marrow transplantation

    • Fanny Urbain
    • Mathieu Puyade
    • Dominique Farge-Bancel

    Letter to the Editors 02 March 2021 Pages: 1536 - 1539

    

47. Therapeutic recommendations and seasonal influenza vaccine for multiple sclerosis patients in treatment with ocrelizumab: an expert consensus

    • Massimo Filippi
    • Ruggero Capra
    • Maria Trojano

    Letter to the Editors Open access 20 February 2021 Pages: 1540 - 1543

48. Neurological updates: neurological complications of CAR-T therapy

    • Emma C. Tallantyre
    • Nia A. Evans
    • Wendy Ingram

    Neurological Update Open access 02 November 2020 Pages: 1544 - 1554

    

49. Spontaneous intracranial hypotension: features, diagnosis and management

    • Tom H. Massey
    • Neil P. Robertson

    Journal club Open access 08 March 2021 Pages: 1555 - 1557

50. Giovanni Mingazzini (1859–1929)

    • Lazaros C. Triarhou

    Pioneers in Neurology 24 April 2020 Pages: 1558 - 1559